0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Compound Glycyrrhizin for Injection Market Research Report 2025
Published Date: 2025-02-13
|
Report Code: QYRE-Auto-3K12894
Home | Market Reports
Global Compound Glycyrrhizin for Injection Market Research Report 2022
BUY CHAPTERS

Global Compound Glycyrrhizin for Injection Market Research Report 2025

Code: QYRE-Auto-3K12894
Report
2025-02-13
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Compound Glycyrrhizin for Injection Market

The global market for Compound Glycyrrhizin for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Compound glycyrrhizin for injection is a medication that contains a compound derived from licorice root called glycyrrhizin. It is used to treat a variety of liver diseases, including chronic hepatitis B and C, liver cirrhosis, and liver failure.
North American market for Compound Glycyrrhizin for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Compound Glycyrrhizin for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Compound Glycyrrhizin for Injection include Shanxi PUDE Pharmaceutical, Xi'an Lijun Pharmaceutical, Beijing Kawin Technology Share-Holding, CSPC OUYI Pharmaceutical, North China Pharmaceutical, Cisen Pharmaceutical, Harbin Medisan Pharmaceutical, Anhui Hongye Pharmaceutical, Reyoung Pharmaceutical, Chengdu Easton Bio Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Compound Glycyrrhizin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compound Glycyrrhizin for Injection.
The Compound Glycyrrhizin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Compound Glycyrrhizin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compound Glycyrrhizin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Compound Glycyrrhizin for Injection Market Report

Report Metric Details
Report Name Compound Glycyrrhizin for Injection Market
Segment by Type
  • Intravenous Injection
  • Intravenous Drip
Segment by Application
  • Chronic Liver Disease
  • Eczema
  • Dermatitis
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shanxi PUDE Pharmaceutical, Xi'an Lijun Pharmaceutical, Beijing Kawin Technology Share-Holding, CSPC OUYI Pharmaceutical, North China Pharmaceutical, Cisen Pharmaceutical, Harbin Medisan Pharmaceutical, Anhui Hongye Pharmaceutical, Reyoung Pharmaceutical, Chengdu Easton Bio Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Compound Glycyrrhizin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Compound Glycyrrhizin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Compound Glycyrrhizin for Injection Market report?

Ans: The main players in the Compound Glycyrrhizin for Injection Market are Shanxi PUDE Pharmaceutical, Xi'an Lijun Pharmaceutical, Beijing Kawin Technology Share-Holding, CSPC OUYI Pharmaceutical, North China Pharmaceutical, Cisen Pharmaceutical, Harbin Medisan Pharmaceutical, Anhui Hongye Pharmaceutical, Reyoung Pharmaceutical, Chengdu Easton Bio Pharmaceuticals

What are the Application segmentation covered in the Compound Glycyrrhizin for Injection Market report?

Ans: The Applications covered in the Compound Glycyrrhizin for Injection Market report are Chronic Liver Disease, Eczema, Dermatitis, Other

What are the Type segmentation covered in the Compound Glycyrrhizin for Injection Market report?

Ans: The Types covered in the Compound Glycyrrhizin for Injection Market report are Intravenous Injection, Intravenous Drip

1 Compound Glycyrrhizin for Injection Market Overview
1.1 Product Definition
1.2 Compound Glycyrrhizin for Injection by Type
1.2.1 Global Compound Glycyrrhizin for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intravenous Injection
1.2.3 Intravenous Drip
1.3 Compound Glycyrrhizin for Injection by Application
1.3.1 Global Compound Glycyrrhizin for Injection Market Value by Application (2024 VS 2031)
1.3.2 Chronic Liver Disease
1.3.3 Eczema
1.3.4 Dermatitis
1.3.5 Other
1.4 Global Compound Glycyrrhizin for Injection Market Size Estimates and Forecasts
1.4.1 Global Compound Glycyrrhizin for Injection Revenue 2020-2031
1.4.2 Global Compound Glycyrrhizin for Injection Sales 2020-2031
1.4.3 Global Compound Glycyrrhizin for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Compound Glycyrrhizin for Injection Market Competition by Manufacturers
2.1 Global Compound Glycyrrhizin for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Compound Glycyrrhizin for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Compound Glycyrrhizin for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Compound Glycyrrhizin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Compound Glycyrrhizin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Compound Glycyrrhizin for Injection, Product Type & Application
2.7 Global Key Manufacturers of Compound Glycyrrhizin for Injection, Date of Enter into This Industry
2.8 Global Compound Glycyrrhizin for Injection Market Competitive Situation and Trends
2.8.1 Global Compound Glycyrrhizin for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Compound Glycyrrhizin for Injection Players Market Share by Revenue
2.8.3 Global Compound Glycyrrhizin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Compound Glycyrrhizin for Injection Market Scenario by Region
3.1 Global Compound Glycyrrhizin for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Compound Glycyrrhizin for Injection Sales by Region: 2020-2031
3.2.1 Global Compound Glycyrrhizin for Injection Sales by Region: 2020-2025
3.2.2 Global Compound Glycyrrhizin for Injection Sales by Region: 2026-2031
3.3 Global Compound Glycyrrhizin for Injection Revenue by Region: 2020-2031
3.3.1 Global Compound Glycyrrhizin for Injection Revenue by Region: 2020-2025
3.3.2 Global Compound Glycyrrhizin for Injection Revenue by Region: 2026-2031
3.4 North America Compound Glycyrrhizin for Injection Market Facts & Figures by Country
3.4.1 North America Compound Glycyrrhizin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Compound Glycyrrhizin for Injection Sales by Country (2020-2031)
3.4.3 North America Compound Glycyrrhizin for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Compound Glycyrrhizin for Injection Market Facts & Figures by Country
3.5.1 Europe Compound Glycyrrhizin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Compound Glycyrrhizin for Injection Sales by Country (2020-2031)
3.5.3 Europe Compound Glycyrrhizin for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Compound Glycyrrhizin for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Compound Glycyrrhizin for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Compound Glycyrrhizin for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Compound Glycyrrhizin for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Compound Glycyrrhizin for Injection Market Facts & Figures by Country
3.7.1 Latin America Compound Glycyrrhizin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Compound Glycyrrhizin for Injection Sales by Country (2020-2031)
3.7.3 Latin America Compound Glycyrrhizin for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Compound Glycyrrhizin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Compound Glycyrrhizin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Compound Glycyrrhizin for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Compound Glycyrrhizin for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Compound Glycyrrhizin for Injection Sales by Type (2020-2031)
4.1.1 Global Compound Glycyrrhizin for Injection Sales by Type (2020-2025)
4.1.2 Global Compound Glycyrrhizin for Injection Sales by Type (2026-2031)
4.1.3 Global Compound Glycyrrhizin for Injection Sales Market Share by Type (2020-2031)
4.2 Global Compound Glycyrrhizin for Injection Revenue by Type (2020-2031)
4.2.1 Global Compound Glycyrrhizin for Injection Revenue by Type (2020-2025)
4.2.2 Global Compound Glycyrrhizin for Injection Revenue by Type (2026-2031)
4.2.3 Global Compound Glycyrrhizin for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Compound Glycyrrhizin for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Compound Glycyrrhizin for Injection Sales by Application (2020-2031)
5.1.1 Global Compound Glycyrrhizin for Injection Sales by Application (2020-2025)
5.1.2 Global Compound Glycyrrhizin for Injection Sales by Application (2026-2031)
5.1.3 Global Compound Glycyrrhizin for Injection Sales Market Share by Application (2020-2031)
5.2 Global Compound Glycyrrhizin for Injection Revenue by Application (2020-2031)
5.2.1 Global Compound Glycyrrhizin for Injection Revenue by Application (2020-2025)
5.2.2 Global Compound Glycyrrhizin for Injection Revenue by Application (2026-2031)
5.2.3 Global Compound Glycyrrhizin for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Compound Glycyrrhizin for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shanxi PUDE Pharmaceutical
6.1.1 Shanxi PUDE Pharmaceutical Company Information
6.1.2 Shanxi PUDE Pharmaceutical Description and Business Overview
6.1.3 Shanxi PUDE Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shanxi PUDE Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.1.5 Shanxi PUDE Pharmaceutical Recent Developments/Updates
6.2 Xi'an Lijun Pharmaceutical
6.2.1 Xi'an Lijun Pharmaceutical Company Information
6.2.2 Xi'an Lijun Pharmaceutical Description and Business Overview
6.2.3 Xi'an Lijun Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Xi'an Lijun Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.2.5 Xi'an Lijun Pharmaceutical Recent Developments/Updates
6.3 Beijing Kawin Technology Share-Holding
6.3.1 Beijing Kawin Technology Share-Holding Company Information
6.3.2 Beijing Kawin Technology Share-Holding Description and Business Overview
6.3.3 Beijing Kawin Technology Share-Holding Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Kawin Technology Share-Holding Compound Glycyrrhizin for Injection Product Portfolio
6.3.5 Beijing Kawin Technology Share-Holding Recent Developments/Updates
6.4 CSPC OUYI Pharmaceutical
6.4.1 CSPC OUYI Pharmaceutical Company Information
6.4.2 CSPC OUYI Pharmaceutical Description and Business Overview
6.4.3 CSPC OUYI Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CSPC OUYI Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.4.5 CSPC OUYI Pharmaceutical Recent Developments/Updates
6.5 North China Pharmaceutical
6.5.1 North China Pharmaceutical Company Information
6.5.2 North China Pharmaceutical Description and Business Overview
6.5.3 North China Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 North China Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.5.5 North China Pharmaceutical Recent Developments/Updates
6.6 Cisen Pharmaceutical
6.6.1 Cisen Pharmaceutical Company Information
6.6.2 Cisen Pharmaceutical Description and Business Overview
6.6.3 Cisen Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cisen Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.6.5 Cisen Pharmaceutical Recent Developments/Updates
6.7 Harbin Medisan Pharmaceutical
6.7.1 Harbin Medisan Pharmaceutical Company Information
6.7.2 Harbin Medisan Pharmaceutical Description and Business Overview
6.7.3 Harbin Medisan Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Harbin Medisan Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.7.5 Harbin Medisan Pharmaceutical Recent Developments/Updates
6.8 Anhui Hongye Pharmaceutical
6.8.1 Anhui Hongye Pharmaceutical Company Information
6.8.2 Anhui Hongye Pharmaceutical Description and Business Overview
6.8.3 Anhui Hongye Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Anhui Hongye Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.8.5 Anhui Hongye Pharmaceutical Recent Developments/Updates
6.9 Reyoung Pharmaceutical
6.9.1 Reyoung Pharmaceutical Company Information
6.9.2 Reyoung Pharmaceutical Description and Business Overview
6.9.3 Reyoung Pharmaceutical Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Reyoung Pharmaceutical Compound Glycyrrhizin for Injection Product Portfolio
6.9.5 Reyoung Pharmaceutical Recent Developments/Updates
6.10 Chengdu Easton Bio Pharmaceuticals
6.10.1 Chengdu Easton Bio Pharmaceuticals Company Information
6.10.2 Chengdu Easton Bio Pharmaceuticals Description and Business Overview
6.10.3 Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin for Injection Product Portfolio
6.10.5 Chengdu Easton Bio Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Compound Glycyrrhizin for Injection Industry Chain Analysis
7.2 Compound Glycyrrhizin for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Compound Glycyrrhizin for Injection Production Mode & Process Analysis
7.4 Compound Glycyrrhizin for Injection Sales and Marketing
7.4.1 Compound Glycyrrhizin for Injection Sales Channels
7.4.2 Compound Glycyrrhizin for Injection Distributors
7.5 Compound Glycyrrhizin for Injection Customer Analysis
8 Compound Glycyrrhizin for Injection Market Dynamics
8.1 Compound Glycyrrhizin for Injection Industry Trends
8.2 Compound Glycyrrhizin for Injection Market Drivers
8.3 Compound Glycyrrhizin for Injection Market Challenges
8.4 Compound Glycyrrhizin for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Compound Glycyrrhizin for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Compound Glycyrrhizin for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Compound Glycyrrhizin for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Compound Glycyrrhizin for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Compound Glycyrrhizin for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Compound Glycyrrhizin for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Compound Glycyrrhizin for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Compound Glycyrrhizin for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Compound Glycyrrhizin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Compound Glycyrrhizin for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Compound Glycyrrhizin for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Compound Glycyrrhizin for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Compound Glycyrrhizin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compound Glycyrrhizin for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Compound Glycyrrhizin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Compound Glycyrrhizin for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Compound Glycyrrhizin for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Compound Glycyrrhizin for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Compound Glycyrrhizin for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Compound Glycyrrhizin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Compound Glycyrrhizin for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Compound Glycyrrhizin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Compound Glycyrrhizin for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Compound Glycyrrhizin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Compound Glycyrrhizin for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Compound Glycyrrhizin for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Compound Glycyrrhizin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Compound Glycyrrhizin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Compound Glycyrrhizin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Compound Glycyrrhizin for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Compound Glycyrrhizin for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Compound Glycyrrhizin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Compound Glycyrrhizin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Compound Glycyrrhizin for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Compound Glycyrrhizin for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Compound Glycyrrhizin for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Compound Glycyrrhizin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Compound Glycyrrhizin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Compound Glycyrrhizin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Compound Glycyrrhizin for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Compound Glycyrrhizin for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Compound Glycyrrhizin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Compound Glycyrrhizin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Compound Glycyrrhizin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Compound Glycyrrhizin for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Compound Glycyrrhizin for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Compound Glycyrrhizin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Compound Glycyrrhizin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Compound Glycyrrhizin for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Compound Glycyrrhizin for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Compound Glycyrrhizin for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Compound Glycyrrhizin for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Compound Glycyrrhizin for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Compound Glycyrrhizin for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Compound Glycyrrhizin for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Compound Glycyrrhizin for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Compound Glycyrrhizin for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Compound Glycyrrhizin for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Compound Glycyrrhizin for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Compound Glycyrrhizin for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Compound Glycyrrhizin for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Compound Glycyrrhizin for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Compound Glycyrrhizin for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Compound Glycyrrhizin for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Compound Glycyrrhizin for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Compound Glycyrrhizin for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Compound Glycyrrhizin for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Compound Glycyrrhizin for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Shanxi PUDE Pharmaceutical Company Information
 Table 71. Shanxi PUDE Pharmaceutical Description and Business Overview
 Table 72. Shanxi PUDE Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Shanxi PUDE Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 74. Shanxi PUDE Pharmaceutical Recent Developments/Updates
 Table 75. Xi'an Lijun Pharmaceutical Company Information
 Table 76. Xi'an Lijun Pharmaceutical Description and Business Overview
 Table 77. Xi'an Lijun Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Xi'an Lijun Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 79. Xi'an Lijun Pharmaceutical Recent Developments/Updates
 Table 80. Beijing Kawin Technology Share-Holding Company Information
 Table 81. Beijing Kawin Technology Share-Holding Description and Business Overview
 Table 82. Beijing Kawin Technology Share-Holding Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Beijing Kawin Technology Share-Holding Compound Glycyrrhizin for Injection Product
 Table 84. Beijing Kawin Technology Share-Holding Recent Developments/Updates
 Table 85. CSPC OUYI Pharmaceutical Company Information
 Table 86. CSPC OUYI Pharmaceutical Description and Business Overview
 Table 87. CSPC OUYI Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CSPC OUYI Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 89. CSPC OUYI Pharmaceutical Recent Developments/Updates
 Table 90. North China Pharmaceutical Company Information
 Table 91. North China Pharmaceutical Description and Business Overview
 Table 92. North China Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. North China Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 94. North China Pharmaceutical Recent Developments/Updates
 Table 95. Cisen Pharmaceutical Company Information
 Table 96. Cisen Pharmaceutical Description and Business Overview
 Table 97. Cisen Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Cisen Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 99. Cisen Pharmaceutical Recent Developments/Updates
 Table 100. Harbin Medisan Pharmaceutical Company Information
 Table 101. Harbin Medisan Pharmaceutical Description and Business Overview
 Table 102. Harbin Medisan Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Harbin Medisan Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 104. Harbin Medisan Pharmaceutical Recent Developments/Updates
 Table 105. Anhui Hongye Pharmaceutical Company Information
 Table 106. Anhui Hongye Pharmaceutical Description and Business Overview
 Table 107. Anhui Hongye Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Anhui Hongye Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 109. Anhui Hongye Pharmaceutical Recent Developments/Updates
 Table 110. Reyoung Pharmaceutical Company Information
 Table 111. Reyoung Pharmaceutical Description and Business Overview
 Table 112. Reyoung Pharmaceutical Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Reyoung Pharmaceutical Compound Glycyrrhizin for Injection Product
 Table 114. Reyoung Pharmaceutical Recent Developments/Updates
 Table 115. Chengdu Easton Bio Pharmaceuticals Company Information
 Table 116. Chengdu Easton Bio Pharmaceuticals Description and Business Overview
 Table 117. Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin for Injection Product
 Table 119. Chengdu Easton Bio Pharmaceuticals Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Compound Glycyrrhizin for Injection Distributors List
 Table 123. Compound Glycyrrhizin for Injection Customers List
 Table 124. Compound Glycyrrhizin for Injection Market Trends
 Table 125. Compound Glycyrrhizin for Injection Market Drivers
 Table 126. Compound Glycyrrhizin for Injection Market Challenges
 Table 127. Compound Glycyrrhizin for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Compound Glycyrrhizin for Injection
 Figure 2. Global Compound Glycyrrhizin for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Compound Glycyrrhizin for Injection Market Share by Type: 2024 & 2031
 Figure 4. Intravenous Injection Product Picture
 Figure 5. Intravenous Drip Product Picture
 Figure 6. Global Compound Glycyrrhizin for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Compound Glycyrrhizin for Injection Market Share by Application: 2024 & 2031
 Figure 8. Chronic Liver Disease
 Figure 9. Eczema
 Figure 10. Dermatitis
 Figure 11. Other
 Figure 12. Global Compound Glycyrrhizin for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Compound Glycyrrhizin for Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Compound Glycyrrhizin for Injection Sales (2020-2031) & (K Units)
 Figure 15. Global Compound Glycyrrhizin for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 16. Compound Glycyrrhizin for Injection Report Years Considered
 Figure 17. Compound Glycyrrhizin for Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Compound Glycyrrhizin for Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Compound Glycyrrhizin for Injection Players: Market Share by Revenue in Compound Glycyrrhizin for Injection in 2024
 Figure 20. Compound Glycyrrhizin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Compound Glycyrrhizin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Compound Glycyrrhizin for Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Compound Glycyrrhizin for Injection Revenue Market Share by Country (2020-2031)
 Figure 24. United States Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Compound Glycyrrhizin for Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Compound Glycyrrhizin for Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Compound Glycyrrhizin for Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Compound Glycyrrhizin for Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Compound Glycyrrhizin for Injection Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Compound Glycyrrhizin for Injection Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Compound Glycyrrhizin for Injection Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Compound Glycyrrhizin for Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Compound Glycyrrhizin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Compound Glycyrrhizin for Injection by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Compound Glycyrrhizin for Injection by Type (2020-2031)
 Figure 54. Global Compound Glycyrrhizin for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Compound Glycyrrhizin for Injection by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Compound Glycyrrhizin for Injection by Application (2020-2031)
 Figure 57. Global Compound Glycyrrhizin for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 58. Compound Glycyrrhizin for Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS